Fortis Malar Hospitals Ltd

₹ 57.4 -1.12%
07 Dec - close price
fortismalar.com BSE: 523696
About

Fortis Malar Hospitals Limited was incorporated in 1989. The company manages and operates a multispecialty hospital and the Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Ultimate Holding Company.[1][2]

Key Points

Business segments in FY21
In-Patient: 86%
Out-Patient: 14%[1]

Website BSE
  • Market Cap ₹ 107 Cr.
  • Current Price ₹ 57.4
  • High / Low ₹ 78.7 / 48.0
  • Stock P/E
  • Book Value ₹ 39.0
  • Dividend Yield 0.00 %
  • ROCE -1.25 %
  • ROE -9.85 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -9.32% over past five years.
  • Company has a low return on equity of -11.5% over last 3 years.
  • Earnings include an other income of Rs.6.49 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
30.70 27.13 22.16 9.43 17.14 22.84 19.83 23.18 19.93 20.45 22.62 20.10 23.29
32.04 27.50 23.85 15.25 18.61 22.22 19.50 22.28 20.93 20.19 19.35 20.13 21.01
Operating Profit -1.34 -0.37 -1.69 -5.82 -1.47 0.62 0.33 0.90 -1.00 0.26 3.27 -0.03 2.28
OPM % -4.36% -1.36% -7.63% -61.72% -8.58% 2.71% 1.66% 3.88% -5.02% 1.27% 14.46% -0.15% 9.79%
2.02 3.04 3.52 6.89 2.71 3.14 2.36 2.05 1.99 1.77 1.58 1.64 1.50
Interest 1.98 1.95 1.91 1.83 1.81 1.80 1.76 1.72 1.67 1.61 1.55 1.55 1.61
Depreciation 3.05 3.20 3.26 3.21 3.24 3.25 3.18 3.08 3.09 3.12 3.24 3.02 2.91
Profit before tax -4.35 -2.48 -3.34 -3.97 -3.81 -1.29 -2.25 -1.85 -3.77 -2.70 0.06 -2.96 -0.74
Tax % 28.05% 18.55% 26.35% 26.45% 28.35% 27.91% 42.67% 27.57% 0.00% 0.00% 850.00% 0.00% -491.89%
Net Profit -3.14 -2.02 -2.47 -2.92 -2.73 -0.93 -1.29 -1.34 -3.78 -2.70 -0.45 -2.96 -4.38
EPS in Rs -1.68 -1.08 -1.32 -1.56 -1.46 -0.50 -0.69 -0.71 -2.02 -1.44 -0.24 -1.58 -2.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
84 95 98 108 118 130 141 149 145 112 69 86 86
71 81 86 99 110 123 140 147 147 115 76 83 81
Operating Profit 12 14 11 9 8 6 1 2 -2 -3 -6 3 6
OPM % 15% 15% 12% 8% 6% 5% 1% 1% -2% -2% -9% 4% 7%
0 1 49 7 8 7 8 8 10 11 15 7 6
Interest 1 1 1 0 1 0 0 0 1 8 7 7 6
Depreciation 3 3 2 2 3 3 4 4 4 13 13 13 12
Profit before tax 8 11 57 13 12 10 4 6 3 -12 -11 -8 -6
Tax % 34% 28% 24% 34% 34% 36% 30% 41% 26% 25% 30% -0%
Net Profit 5 8 43 9 8 6 3 3 2 -9 -8 -8 -10
EPS in Rs 2.93 4.17 23.38 4.72 4.23 3.45 1.67 1.78 1.10 -4.74 -4.20 -4.41 -5.60
Dividend Payout % 0% 0% 0% 11% 12% 14% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -1%
5 Years: -9%
3 Years: -16%
TTM: 1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -20%
Stock Price CAGR
10 Years: 5%
5 Years: 0%
3 Years: 5%
1 Year: -11%
Return on Equity
10 Years: 1%
5 Years: -5%
3 Years: -11%
Last Year: -10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
19 19 19 19 19 19 19 19 19 19 19 19 19
Reserves 7 15 59 66 73 79 81 84 87 78 70 61 54
7 8 0 0 0 0 0 0 0 64 57 53 50
16 77 14 17 20 33 31 46 45 33 23 27 31
Total Liabilities 48 118 91 101 111 130 131 149 151 194 169 161 154
35 39 17 18 18 24 25 24 22 81 69 58 52
CWIP 0 0 0 1 1 0 1 1 1 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
13 79 73 83 93 105 105 125 128 112 100 103 101
Total Assets 48 118 91 101 111 130 131 149 151 194 169 161 154

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
12 11 -64 5 4 10 -9 9 -16 -0 -1 7
-8 -10 73 -1 5 -22 13 -2 6 50 -28 8
-5 -1 -7 -1 0 -1 -1 0 0 -12 -7 -10
Net Cash Flow -1 0 2 3 10 -13 4 7 -9 38 -36 5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 22 15 12 13 13 17 14 15 24 12 11 9
Inventory Days 8 9 7 4 13 35 28 22 18 22 42 40
Days Payable 165 122 160 153 169 286 174 277 257 324 373 429
Cash Conversion Cycle -136 -98 -141 -136 -143 -234 -131 -240 -215 -289 -320 -380
Working Capital Days -28 -9 212 187 164 126 153 132 156 -55 134 51
ROCE % 28% 30% 23% 17% 14% 12% 5% 6% 3% -3% -7% -1%

Shareholding Pattern

Numbers in percentages

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71
0.19 0.19 0.19 0.19 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
37.10 37.10 37.10 37.10 37.22 37.22 37.22 37.22 37.22 37.22 37.22 37.23

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports